Company Overview and News

 
Aeris Resources has a new substantial shareholder in HSBC Holdings

2018-10-05 proactiveinvestors.com.au
Aeris Resources Ltd (ASX:AIS) has a new substantial shareholder with HSBC Holdings plc (LON:HSBA) holding a 6.36% interest.
HCS ARE HSB ARSRF 0005 AIS AGREF HSEA HSEB HSBC HBCYF

 
Aeris Resources reduces debt by US$20 million

2018-10-04 proactiveinvestors.com.au
Aeris Resources Ltd (ASX:AIS) has today made a US$20 million payment against its Tranche B debt facility with Special Portfolio Opportunity V Limited.
ARSRF AIS

 
Aeris Resources receives $28.4 million cash from capital raising

2018-10-02 proactiveinvestors.com.au
Aeris Resources Ltd (ASX:AIS) has settled $28.4 million in funding as a result of the recently completed placement and institutional entitlement offer.
ARSRF AIS

 
Aeris Resources secures $28.4 million funding with more to come

2018-09-25 proactiveinvestors.com.au
Aeris Resources Ltd (ASX:AIS) has raised $28.4 million through a combined placement and institutional accelerated rights issue offering shares priced at 20 cents.
ARSRF AIS

 
Aeris Resources to bolster operations with $35m equity raising

2018-09-21 australianmining.com.au
Aeris Resources has launched a $35.1 million equity raising to advance its exploration at the Tritton copper mine and Torrens joint venture (JV).
ARSRF AIS

 
Aeris Resources raising $35.1 million to accelerate exploration at Tritton and Torrens

2018-09-21 proactiveinvestors.com.au
Aeris Resources Ltd (ASX:AIS) has launched a fully underwritten $35.1 million equity raising to accelerate the exploration programs at the Tritton Copper Operations (100% Aeris) and the Torrens Joint Venture (70% Aeris).
ARSRF AIS ARE

 
Aeris Resources enters trading halt ahead of capital raising

2018-09-20 proactiveinvestors.com.au
Aeris Resources Ltd (ASX:AIS) has been granted a trading halt by the ASX pending the release of an announcement regarding a capital raising.
ARSRF AIS ARE

 
Aeris Resources ready to drill massive Olympic Dam style target

2018-09-17 proactiveinvestors.com.au
Aeris Resource Ltd (ASX:AIS) has committed funding for the stage one drilling program at the Torrens Copper Project in South Australia.
ARSRF AIS

 
Argonaut Resources green lights major drilling program at Torrens

2018-09-17 proactiveinvestors.com.au
Argonaut Resources NL (ASX:ARE) has resolved to proceed with stage I of a major drilling program at the Torrens Joint Venture in South Australia.
ARSRF AIS AGREF ARE

 
Aeris Resources director supports company’s copper strategy with on-market purchases

2018-09-03 proactiveinvestors.com.au
Aeris Resources Ltd (ASX:AIS) non-executive director Mark Derwin has demonstrated his confidence in the company’s copper strategy by acquiring shares on-market.
ARSRF AIS AGREF ARE

 
S&P Global Market Intelligence highlights 83% reduction in major copper discoveries

2018-08-15 proactiveinvestors.com.au
S&P Global Market Intelligence has found only 140 million significant tonnes of copper were discovered in the last 10 years, a dramatic reduction on the 862.8 million tonnes defined in the 18-year period before the past decade.
ARSRF AUZ AIS AGREF HAV SGQ WNARF AMSLF WSA ARE

 
Aeris Resources marks June quarter as best in FY2018

2018-07-18 proactiveinvestors.com.au
Aeris Resources Ltd (ASX:AIS) achieved copper production for the June quarter of 7,592 tonnes, an 11% increase on the previous quarter and the best quarter for FY2018.
ARSRF AIS

 
Aeris Resources identifies 28 anomalies at Torrens Copper-Gold Project

2018-07-17 proactiveinvestors.com.au
Aeris Resources Ltd (ASX:AIS) has identified 28 anomalies from airborne gravity surveys at its Torrens project in South Australia.
ARSRF AIS AGREF ARE

 
Argonaut Resources identifies iron oxide copper-gold targets at Torrens project

2018-07-16 proactiveinvestors.com.au
Argonaut Resources NL (ASX:ARE) has identified 28 large volume iron oxide copper-gold (IOCG) drilling targets from airborne gravity and magnetic survey data of the Torrens exploration licence in South Australia.
ARSRF AIS AGREF ARE

 
Argonaut Resources NL identifies iron oxide copper-gold targets at Torrens project

2018-07-16 proactiveinvestors.com.au
Argonaut Resources NL (ASX:ARE) has identified 28 large volume iron oxide copper-gold (IOCG) drilling targets from airborne gravity and magnetic survey data of the Torrens exploration licence in South Australia.
ARSRF AIS AGREF ARE

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to ASX:AIS / AERIS RESOURCES LIMITED on message board site Silicon Investor.

Kaiser Bottom Fishes Kaiser Bottom Fishes Kaiser Bottom Fishes new CA travel approval policy raises concerns new CA travel approval policy raises concerns new CA travel approval policy raises concerns
Companhia Energetica de Minas Gerais -- CEMIG Companhia Energetica de Minas Gerais -- CEMIG Companhia Energetica de Minas Gerais -- CEMIG Renaisance u0026 Husky Merger Renaisance u0026 Husky Merger Renaisance u0026 Husky Merger
Genaissance Pharmaceuticals (GNSC) Genaissance Pharmaceuticals (GNSC) Genaissance Pharmaceuticals (GNSC) RNR - RenaissanceRe Holdings RNR - RenaissanceRe Holdings RNR - RenaissanceRe Holdings
KAISERu0027 PICKS AND FAX ALERTS, ***(JOHN KAISER) KAISERu0027 PICKS AND FAX ALERTS, ***(JOHN KAISER) KAISERu0027 PICKS AND FAX ALERTS, ***(JOHN KAISER) URUGUAY, en Espa��ol. Pais Peligroso. URUGUAY, en Espa��ol. Pais Peligroso. URUGUAY, en Espa��ol. Pais Peligroso.
RENN: Renaissance Cap. Growth RENN: Renaissance Cap. Growth RENN: Renaissance Cap. Growth KLU: Kaiser Aluminum Corp. KLU: Kaiser Aluminum Corp. KLU: Kaiser Aluminum Corp.